CD274 and neoplasm: Due to the variable prevalence rates of positivity at different CD274 copy number cutoffs and given the varying responses based on different CD274 copy number cutoffs in the aforementioned clinical studies, it is imperative to find an optimal standardized copy number cutoff for CD274 that is correlated with patient response to ICI in specific tumor types.